Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00648414
Recruitment Status : Terminated (due to multiple subjects reporting pain and burning at the phlebotomy sites after 38hr)
First Posted : April 1, 2008
Last Update Posted : April 1, 2008
Information provided by:
Mylan Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : October 2006
  Study Completion Date : No date given